Publication | Closed Access

Pegylated liposomal mitoxantrone is more therapeutically active than mitoxantrone in L1210 ascitic tumor and exhibits dose-dependent activity saturation effect

Tumor BiologyMedicinePharmacologyL1210 Ascitic TumorPharmacotherapyAnti-cancer AgentTumor TargetingCancer TreatmentOncologyCell BiologyCancer ResearchLiposomal Mitoxantrone